CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024
This report outlines CDC’s recommendation for the use of doxycycline postexposure prophylaxis (doxy PEP), a novel, ongoing, patient-managed biomedical STI prevention strategy for a selected population.
Published by
Centers for Disease Control and Prevention (CDC)
Date
Language(s)
English
Population(s)
Gay, bisexual and other men who have sex with men, Trans people
Audience
Program tools
Resource Type
Guideline or manual